Ohmori Co.,Ltd. (TYO:1844)

Inozyme Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is August - July.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Market Capitalization	11,286	4,328	3,202	2,827	3,001	3,160
Market Cap Growth	7.22%	35.16%	13.28%	-5.82%	-5.01%	-5.76%
Enterprise Value	11,891	5,477	5,091	2,851	3,677	4,530
Last Close Price	605.00	227.08	182.75	171.54	178.56	181.92
PE Ratio	22.87	10.45	10.93	11.13	12.35	9.38
PS Ratio	1.75	0.72	0.53	0.54	0.61	0.61
PB Ratio	1.92	0.77	0.62	0.63	0.70	0.76
P/TBV Ratio	1.92	0.77	0.63	0.64	0.71	0.78
P/FCF Ratio	-	3.07	-	6.23	10.64	19.15
P/OCF Ratio	-	2.93	-	5.61	8.99	16.72
EV/Sales Ratio	1.84	0.92	0.84	0.54	0.74	0.87
EV/EBITDA Ratio	13.73	7.98	10.18	6.97	8.95	7.10
EV/EBIT Ratio	14.59	8.81	12.15	9.08	11.04	8.45
EV/FCF Ratio	-	3.89	-	6.28	13.04	27.45
Debt / Equity Ratio	0.57	0.71	0.85	0.72	0.78	0.82
Debt / EBITDA Ratio	3.89	5.83	8.71	7.92	8.13	5.31
Debt / FCF Ratio	-	2.84	-	7.14	11.85	20.52
Asset Turnover	0.58	0.51	0.58	0.57	0.55	0.60
Inventory Turnover	0.98	0.93	1.10	1.16	1.16	1.41
Quick Ratio	2.48	1.96	2.30	2.02	2.36	1.70
Current Ratio	5.64	3.71	4.74	3.91	4.80	3.01
Return on Equity (ROE)	8.79%	7.69%	6.09%	5.78%	5.75%	8.42%
Return on Assets (ROA)	4.61%	3.33%	2.50%	2.13%	2.31%	3.86%
Return on Capital (ROIC)	5.31%	4.07%	3.04%	2.56%	2.74%	4.65%
Return on Capital Employed (ROCE)	9.00%	6.90%	4.50%	4.20%	4.60%	8.20%
Earnings Yield	4.47%	9.57%	9.15%	8.99%	8.10%	10.67%
FCF Yield	-	32.53%	-65.33%	16.06%	9.40%	5.22%
Dividend Yield	1.64%	4.40%	3.83%	2.92%	3.92%	3.85%
Payout Ratio	-	33.58%	25.60%	40.95%	42.39%	21.96%
Buyback Yield / Dilution	-4.68%	-16.70%	-5.28%	-0.26%	-0.63%	-0.46%
Total Shareholder Return	-3.02%	-12.30%	-1.45%	2.65%	3.29%	3.39%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.